kabutan

Nippi,Incorporated(7932) Summary

7932
TSE Standard
Nippi,Incorporated
12,830
JPY
-90
(-0.70%)
Dec 5, 12:45 pm JST
82.71
USD
Dec 4, 10:45 pm EST
Result
PTS
outside of trading hours
12,875
Dec 5, 9:29 am JST
Summary Chart Historical News Financial Result
PER
14.0
PBR
0.92
Yield
4.93%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
12,900 JPY 83.15 USD
Previous Close Dec 4
12,920 JPY 83.15 USD
High Dec 5, 9:38 am
12,940 JPY 83.42 USD
Low Dec 5, 12:32 pm
12,830 JPY 82.70 USD
Volume
2,000
Trading Value
0.03B JPY 0.17M USD
VWAP
12892.0 JPY 83.09 USD
Minimum Trading Value
1,283,000 JPY 8,271 USD
Market Cap
0.04T JPY 0.24B USD
Number of Trades
15
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly Low
1-Year Average
49
1-Year High May 13, 2025
688
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 169,400
Nov 21, 2025 0 169,400
Nov 14, 2025 0 173,800
Nov 7, 2025 0 173,500
Oct 31, 2025 0 174,100
Company Profile
Nippi, Incorporated specializes in collagen and gelatin products, with a focus on cosmetics. The company also operates in the leather industry and is actively engaged in iPS cell development.
Sector
Other Products
Nippi, Incorporated manufactures and sells collagen and gelatin products as its core business, along with cosmetics and leather-related products. In its collagen casing business, the company manages the entire process from raw material procurement to manufacturing and sales both domestically and internationally. The gelatin-related business similarly maintains a global supply chain. For the cosmetics-related business, Nippi combines in-house manufacturing with OEM commissioning, delivering products to consumers through its mail-order subsidiary. The leather-related business deals with leather for shoes and automobiles. Additionally, the company is involved in real estate leasing and food import sales. In recent years, Nippi has been focusing on the development and manufacturing of iPS cell culture substrates and medical-grade collagen, expanding its presence in the biotechnology field.